GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1

Company

X4 Pharmaceuticals, Inc

Filed

July 19, 2022

Accession Number

0001072613-22-000489

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →